Login to Your Account



Pharma: Other news to note


Wednesday, February 19, 2014
Actavis plc, of Dublin, said it plans to acquire Forest Laboratories Inc., of New York, for a combination of cash and equity valued at approximately $25 billion or $89.48 per Forest share ($26.04 in cash and 0.3306 Actavis shares for each share of Forest common stock).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription